Treatment-resistant depression (TRD)
Sometimes depression doesn’t get better, even with treatment.
About our treatment-resistant depression clinical development programme
We are studying investigational psilocybin therapy (also known as psilocybin treatment) as a treatment for TRD. We have received FDA Breakthrough Therapy designation and Innovative Licensing and Access Pathway designation for our investigational COMP360 psilocybin for TRD.
We’re running a rigorous, global clinical development programme of COMP360 psilocybin treatment for TRD.